CORC  > 天津大学
Elevated serum anti-NMDA receptor antibody levels in first-episode patients with schizophrenia
Tong J.; Huang J.; Luo X.; Chen S.; Cui Y.; An H.; Xiu M.; Tan S.; Wang Z.; Yuan Y.
刊名Brain, Behavior, and Immunity
2019
卷号Vol.81页码:213-219
关键词Anti-NMDA receptor antibody Autoimmunity Biomarker Cognitive impairment First-episode patients with schizophrenia
ISSN号0889-1591
URL标识查看原文
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/2904133
专题天津大学
作者单位Peking University HuiLongGuan Clinical Medical School, Beijing HuiLongGuan Hospital, Beijing, China Department of Psychiatry, Yale University School of Medicine, New Haven, CT, United States Department of Pharmacy, Peking University First Hospital, Beijing, China School of Foreign Languages and Literature, Tianjin University, Tianjin, China Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, United States
推荐引用方式
GB/T 7714
Tong J.,Huang J.,Luo X.,et al. Elevated serum anti-NMDA receptor antibody levels in first-episode patients with schizophrenia[J]. Brain, Behavior, and Immunity,2019,Vol.81:213-219.
APA Tong J..,Huang J..,Luo X..,Chen S..,Cui Y..,...&Tan Y..(2019).Elevated serum anti-NMDA receptor antibody levels in first-episode patients with schizophrenia.Brain, Behavior, and Immunity,Vol.81,213-219.
MLA Tong J.,et al."Elevated serum anti-NMDA receptor antibody levels in first-episode patients with schizophrenia".Brain, Behavior, and Immunity Vol.81(2019):213-219.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace